Obesity is a worldwide epidemic and is known to increase the risk of cardiovascular disease, type 2 diabetes, and certain forms of cancer. In addition, obesity is now recognized as an important risk factor in the development of several respiratory diseases. Of these respiratory diseases, it has already been well established that obesity can lead to obstructive sleep apnea (OSA) and obesity-hypoventilation syndrome (OHS). More recent data suggest that the prevalence of wheezing and bronchial hyper-responsiveness, two symptoms often associated with asthma, are increased in overweight and obese individual. Indeed, epidemiological studies have reported that obesity is a risk factor for the development of asthma. Furthermore, a number of studies indicate that obesity is also associated with a higher risk of developing deep vein thrombi, pulmonary emboli, pulmonary hypertension, and pneumonia. Finally, weight reduction has been shown to be effective in improving the symptoms and severity of several respiratory diseases, including OSA and asthma. Thus, overweight and obese patients should be encouraged to lose weight to reduce their risk of developing respiratory diseases or improve the course of preexisting conditions. Chronic Respiratory Disease 2008; 5: 233-242
Introduction
Obesity is a major public health problem that has become a worldwide epidemic. Globally in 2005, nearly 1.6 billion adults and 20 million children were overweight, whereas approximately 400 million adults were obese. 1 The World Health Organization (WHO) estimates that, by 2015, nearly 2.3 billion adults will be overweight and more than 700 million will be obese. 1 Once considered a problem only in developed countries, overweight and obesity are now dramatically increasing in lessdeveloped countries, primarily because of an increased intake of energy-dense foods and more sedentary lifestyles promoted by urbanization. [1] [2] [3] [4] Obesity impairs health-related quality of life and is a major cause of morbidity and premature mortality because of an increased risk of developing type 2 diabetes, hypertension, hyperlipidemia, atherosclerosis, gall bladder and liver disease, gout, and cancer. [5] [6] [7] [8] [9] [10] [11] In the United States, medical illnesses associated with obesity incur an annual economic burden of 70-100 billion dollars, or approximately 8.4% of the national healthcare expenditure. 12, 13 Finally, obesity-related mortality is second only to tobacco-related mortality as the leading cause of preventable death in the United States. 14 
Definition of overweight and obesity
Overweight and obesity are conditions in which a person has excess body weight relative to others of the same gender and height. Degree of weight relative to normal is commonly expressed in terms of body mass index (BMI; kg/m 2 ), and categorized as: underweight (BMI < 18.5), normal weight (BMI = 18.5-24.9), overweight (BMI = 25.0-29.9), and obese (BMI ≥ 30). 15, 16 Obesity is further subdivided into classes: class I (BMI = 30.0-34.9), class II (BMI = 35.0-39.9), and class III or extreme obesity (BMI > 40). 15, 16 BMI, however, does not provide information on the distribution of fat in the body, an important determinant of obesity's effects on physiologic functions, particularly respiratory function. Waist circumference, in conjunction with BMI, assists in the assessment of the effects of obesity on an individual's health. For example, overweight and obesity increase the risk of cardiovascular disease and type 2 diabetes 17 ; however, the risk of these diseases is increased to a greater extent in overweight or obese men with a waist circumference greater than 102 cm and overweight or obese women with a waist circumference greater than 88 cm. Table 1 provides the classification of overweight and obesity based on BMI and waist circumference and risk of cardiovascular disease and type 2 diabetes. 15, 16 
Impact of obesity on respiratory physiology
Obesity leads to alterations in respiratory mechanics, airway resistance, pattern of breathing, respiratory drive, and gas exchange. 18, 19 These changes are thought to be due to the increased elastic load posed by excess weight on the thorax and abdomen, increased pulmonary blood volume, and ventilation-perfusion mismatch. 20 The effect of excess body weight on respiratory function is summarized in Table 2 .
Association between obesity and respiratory diseases
Obesity is a well-known risk factor for cardiovascular disease, type 2 diabetes, and some forms of cancer [15] [16] [17] ; however, it is increasingly apparent that obesity is also a risk factor for development of certain respiratory diseases. In the remainder of this article, we discuss the impact of obesity on the association, development, and prognosis of various respiratory diseases (Table 3) .
Obstructive sleep apnea
Obstructive sleep apnea (OSA) is extremely common in the obese. OSA is characterized by intermittent upper airway collapse because of the inability of pharyngeal muscles to maintain upper airway patency leading to apneas and hypopneas. 22, 23 These pauses in breathing result in hypoxia, hypercapnia, increased sympathetic activity, increased respiratory effort, cortical arousal, and sleep fragmentation. 22, 23 Restless sleep leads to functional impairments, which compromise performance at home, school, or work. 24 Physiologic consequences of OSA include neuropsychiatric disturbances relating to sleep deprivation, as well as cardiac 20, 23, 25, 26 Untreated OSA is associated with increased mortality. 25 OSA is underdiagnosed and affects up to 2% of women and 4% of men 30-65 years of age. 27 In men with a BMI greater than 40 kg/m 2 , the prevalence of OSA is 40%. 27 To diagnose OSA, the American Academy of Sleep Medicine requires that the individual have excessive daytime sleepiness that is not explained by other factors or the presence of two or more of the following: 1) choking or gasping during sleep, 2) recurrent awakenings from sleep, 3) unrefreshing sleep, 4) daytime fatigue, and 5) impaired concentration. The presence of five or more apneas or hypoapneas per hour (apnea-hypoapnea index; AHI) on an overnight polysomnogram confirms the diagnosis of OSA. 22 OSA is classified as mild (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) , moderate (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) , or severe (>30), according to the AHI. 22 Obesity, a large neck circumference (>43 cm), and abnormal craniofacial and upper airway structures can lead to development of a small retropharyngeal opening space, leading to the development of OSA. Sixty to ninety percent of those with OSA have one or more of the above-mentioned physical features. 22,28 A 4-year follow-up of a subgroup of patients (n = 690) enrolled in the Wisconsin Sleep Cohort Study reported that, in subjects who were initially free of OSA, a 10% increase in weight was associated with a sixfold increased risk of developing OSA. 29 Furthermore, in patients already diagnosed with OSA, a 10% increase in weight predicted an approximate 32% increase in the AHI and a 10% decrease in weight predicted a 26% decrease in the AHI. 29 These data strongly suggest a causal relationship between obesity and OSA.
The mainstay therapy for OSA includes nasal continuous positive airway pressure (CPAP), oral appliances, surgical interventions, including the correction of anatomic abnormalities such as micrognathia or enlarged tonsils, sleep-position training, and tracheostomy. 20, 25 Bi-level pressure ventilation is usually needed to maintain effective ventilation and gas exchange among people with concomitant nocturnal alveolar hypoventilation and OSA. Weight loss has been shown to consistently and substantially decrease OSA severity and improve mortality. A recent study of dietary weight loss program on OSA showed a 60% reduction in AHI over 1.5 years in the intervention group compared with age-and weight-matched control subjects. 30 
Obesity-hypoventilation syndrome
Obesity-hypoventilation syndrome (OHS) is characterized by a triad of obesity, daytime hypoxemia, and diurnal hypoventilation, as defined by PaCO 2 > 45 mmHg in the absence of other causes of hypoventilation. 22 Polysomnography or nocturnal oximetry is used to diagnose OHS by the presence of non-apneic hypoxemia. These patients develop chronic complications of hypoxemia such as polycythemia, pulmonary hypertension, cardiac dysrhythmias, and right heart failure more frequently than do patients with OSA. 31, 32 OHS is present in more than half of extremely obese patients and one-fifth of patients with OSA. Blunted chemoresponsiveness to chronic hypoxia and hypercapnia increased mechanical impedance to breathing, reduced central respiratory drive and leptin resistance have been proposed to play a role in the pathogenesis of OHS. 33, 34 Nowbar, et al. prospectively evaluated 150 severely obese (BMI > 35 kg/m 2 ) patients admitted to the hospital with a sleep questionnaire, arterial blood gas, neuropsychological, and pulmonary function testing and followed them for 18 months. Forty-seven (31%) of the subjects had evidence of hypoventilation as defined by arterial partial pressure of carbon dioxide (PaCO 2 ) ≥ 43 mm Hg, without any other identifiable reasons for hypercapnia. Patients with OHS had higher rates of intensive care (40% vs 26%), long-term care at discharge (19% vs 2%), and need for mechanical ventilation (6% vs 0%) compared with those without OHS. At 18 months following hospital discharge, the risk of mortality was 2.5 times higher in the OHS group (23%) as compared with the simple obese group (9%). Most deaths associated with OHS occurred in the first 3 months following hospital discharge, whereas only 23% of patients with hypoventilation were given the diagnosis of OHS and only 13% were discharged with a recommendation for long-term treatment for hypoventilation. 35 Weight reduction is the only effective treatment for OHS. If diet and exercise fail, bariatric surgery is an option. CPAP with supplemental oxygen may be useful in cases with associated OSA. A recent prospective study evaluated the effect of one-night of CPAP titration on sleep architecture, arousal indexes, and sleep-disordered breathing parameters in extremely obese subjects (BMI ≥ 50 kg/m 2 ) recently diagnosed with OSA. The control group was extremely obese subjects diagnosed with OSA alone. In spite of similar reductions in AHI, significant improvements in sleep architecture and arousal indexes, 43% of patients with concomitant OHS continued to have significant nocturnal desaturation compared with 9% of patients with OSA alone. 36 Non-responders had higher BMI, more severe nocturnal hypoxemia at baseline, and a higher residual AHI. Continuous desaturation despite relief of upper airway obstruction with CPAP in patients with OHS is likely related to worsening AHI during REM sleep and baseline respiratory failure. Persistence of nocturnal desaturation on CPAP may be helpful in identifying patients who may benefit from bi-level ventilation until their daytime respiratory failure and hypercapnia resolves. 37 
Obesity and asthma
Asthma is a chronic airway disease characterized by reversible airway obstruction, airway inflammation, and airway hyperresponsiveness. 38 It affects 7% of the US population. 39 During the last several decades, the worldwide incidences of both obesity and asthma have dramatically increased, [40] [41] [42] which suggests that the concomitant escalation of both of these conditions may be casually related. Indeed, data from both retrospective (cross-sectional) and prospective (longitudinal) studies report an increased prevalence of asthma in the overweight and obese.
Retrospective studies
One of the first reports identifying an association between symptoms of asthma and overweight was published in 1984. 43 In this study, the relationship between overweight and seven respiratory symptoms, including wheezing, was investigated in children between the ages of 5 and 11 living in Great Britain in 1977. This report was subsequently followed by many retrospective or cross-sectional studies examining the relationship between BMI and prevalence of asthma in children and adolescents ranging from 1 to 17 years of age. [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] All but three of these studies 48, 49, 56 reported greater incidences of asthma in overweight and obese children and adolescents. Although Schachter, et al. 49 did not find a relationship between BMI and asthma, the authors did report that a higher BMI was associated with wheeze and cough, two symptoms often associated with asthma.
Many retrospective studies have also described an association between BMI and asthma in adults. The first such report, published in 1986, examined the relationship between BMI and the prevalence of certain chronic diseases such as diabetes, hypertension, or asthma in 19,126 Dutch men and women who were personally interviewed in 1981, 1982, or 1983. 59 The authors reported that obese women had nearly twice the odds of having asthma as compared with those of normal body mass. Two years later, these findings of Seidell, et al. 59 were corroborated by Negri, et al., 60 who reported that obese men and women greater than 15 years of age have higher odds of having asthma than individuals with a normal BMI. Subsequently, at least 19 retrospective studies examining the prevalence of asthma in overweight or obese adults have been published. [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] Consistent with the reports of Seidell and Negri, each of these studies reported an increased incidence of asthma or symptoms indicative of asthma in overweight or obese adults. Interestingly, several of these retrospective studies in adults as well as children and adolescents reported an association between obesity and asthma in women exclusively, 46, 52, 55, 59, 73, 75, 76 which suggests the existence of a gender bias in the relationship between obesity and asthma. However, further study is needed to clarify these apparent gender differences.
These abovementioned cross-sectional studies, involving several thousands of individuals of different genders, ages, and ethnicities, clearly indicate a positive association between obesity and asthma, yet they could not determine the direction of causality in this relationship. Thus, prospective studies are needed to definitively determine the direction of causality between these two conditions.
Prospective studies
The first prospective study examining the relationship between BMI and the risk of new-onset asthma was published in 1999 by Camargo, et al. 80 The initial pool of study participants included 116,678 women, US registered nurses from the Nurses' Health Study II. After excluding thousands of individuals because of potential confounders, including those who received a physician's diagnosis of asthma before the start of the study in 1991, 85 ,911 subjects were included in the final analysis. These remaining participants were followed for a period of 4 years, and any subject who received a physician's diagnosis of asthma between 1991 and 1995 was asked to report this information. Between 1991 and 1995, 1596 of the 85,911 participants reported receiving a doctor's diagnosis of asthma. Camargo, et al. reported a strong, dose-response relationship between BMI, calculated from selfreported weight and height in 1991, and the relative risk of new-onset asthma in the 4-year follow-up period. The multivariate relative risk for incident asthma for the obese (BMI ≥ 30) was 2.7 after correcting for a number of confounding factors, such as smoking, physical activity, and total energy intake. This was the first study to report that obesity antedates or precedes the development of asthma. Eight other prospective studies examining the relationship between obesity and asthma in adults followed that of Camargo, et al., [81] [82] [83] [84] [85] [86] [87] [88] and all but two 81, 84 reported that obesity precedes the development of asthma. The study by Hasler, et al. reported that asthma preceded the development of obesity 84 involved only 591 adults, whereas the other prospective studies involved thousands.
Two years later, the first longitudinal study examining the relationship between BMI and odds of developing asthma in children was published. 89 Castro-Rodriguez, et al. reported that women who became overweight or obese between the ages of 6 and 11 had 6-7 times the odds of developing asthma as adolescents than those who did not become overweight or obese. Furthermore, overweight or obese girls were significantly more likely to respond to the β 2 -adrenergic agonist and bronchodilator albuterol after gaining excessive weight. Thus, overweight or obesity preceded the development of asthma in children in addition to predicting future responses to albuterol. No such associations were found in boys. Obesity was also found to antedate the development of asthma in five other prospective studies with children and/or adolescents as subjects. [90] [91] [92] [93] [94] As with the cross-sectional studies, many of these prospective studies showed a gender bias in the relationship between obesity and asthma. For example, four of the prospective studies reported a greater effect in women than in men. 85, [87] [88] [89] Four other studies, however, reported a greater impact of obesity on the development of asthma in men than in women. 83, 86, 90, 93 Currently, there are not enough data to support a gender bias in the relationship between obesity and asthma. As stated earlier, this apparent gender bias needs more active investigation.
Many studies report that either diet or surgically induced weight loss can improve both the severity and symptoms of asthma. [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] In overweight and obese asthmatics following weight loss, several of these aforementioned studies have reported a decrease in asthma severity and symptoms, medication use, and significant improvements in lung function parameters, including peak expiratory flow (PEF), forced expiratory volume in 1 s (FEV 1 ), and forced vital capacity. Thus, health care professionals should encourage overweight and obese asthmatics to reduce their weight as an effective strategy to improve the course of their disease.
Pneumonia
One prospective study has examined the relationship between BMI and the risk of communityacquired pneumonia (CAP) among men and women. 105 The subject population consisted of 26,429 men from the Health Professionals Followup Study and 78,062 women from the Nurses' Health Study II. Of the men, 290 of them reported receiving a physician's diagnosis of pneumonia between the start of the analysis in 1991 until its conclusion in 1996. The diagnosis of pneumonia in men was confirmed by an examination of their medical records. Among men, the authors reported no direct relationship between BMI, calculated from self-reported weight and height in 1991, and the relative risk of CAP. However, men whose body mass increased by 40 or more pounds since the age of 21 had nearly 1.8 times the risk of acquiring CAP than those whose body mass remained virtually unchanged. In women, there were 305 self-reported cases of CAP. Data from women showed a linear relationship between BMI and CAP, such that the multivariate relative risk was 2.22 times greater for obese women than those of normal weight. Similar to men, women who gained 40 or more pounds as adults had a greater than twofold risk of acquiring CAP. At the time this review went to press, this was the first and only prospective study investigating the association between BMI and CAP. Because respiratory infections are responsible for the greatest burden of disease worldwide, 106 and because the incidence of obesity continues to escalate in both the developed and less-developed countries, [107] [108] [109] [110] more prospective studies examining the relationship between BMI and CAP are needed to confirm the findings of this initial study.
Deep venous thrombosis and pulmonary embolism
Obesity is a major independent risk factor for venous thromboembolism (VTE). 111 The risk of pulmonary embolism (PE) is higher among obese than normal weight women. 112 Recent data from the National Hospital Discharge Survey database shows a relative risk of 2.50 for deep venous thrombosis (DVT) and a relative risk of 2.21 for PE among obese hospitalized patients compared with nonobese ones. Obese women had a greater relative risk (2.75) of DVT than obese men (2.02). 113 Immobility, endothelial dysfunction, and reduction in fibrinolysis are mechanisms proposed to account for this increased risk among the obese. Therefore, prophylaxis against VTE is crucial in the obese patient. Unfractionated heparin, low molecular weight heparin (LMWH), and pneumatic compression are all options for DVT prophylaxis. 114 However, the optimal strategy for the use of these methods is not wellestablished among obese people and warrants further study. In particular, it is not clear that conventional subcutaneous dosing of heparin is sufficient to reduce DVT/PE risk to a degree comparable with that for non-obese individuals. In extremely obese patients undergoing bariatric surgery, the current recommendation is to use a multi-modal approach that includes early ambulation, graduated compression stockings, intermittent pneumatic compression, LMWH and, in high-risk patients, prophylactic insertion of a vena caval filter or warfarin for 3 months. 115 A prospective study following 481 patients who underwent primary and revisional bariatric surgery showed that LMWH 40 mg q12h, which is double the dose for nonobese patients, may reduce the incidence of DVT complications without an increase in bleeding complications. 116 Hamad, et al. 117 added that extended thromboprophylaxis may be of value because all thromboembolic events in that study occurred after cessation of thromboprophylaxis.
Pulmonary hypertension
Primary pulmonary hypertension (PPH), once a disease of young women, is now rising among overweight or obese postmenopausal women. A retrospective review of medical records of 541 postmenopausal patients at a university referral center for pulmonary hypertension showed that 39% of postmenopausal women with PPH and 48% with severe secondary PH were obese. 118 This association has yet to be confirmed by further studies. Several retrospective studies have also found a strong association between OSA and pulmonary hypertension, possibly because of hypoxemia, hypercapnia, and increased sympathetic activity. 119 In a study of 20 ambulatory patients visiting a suburban family practice clinic presenting with unexplained bilateral leg edema and echocardiographic evidence of pulmonary hypertension, almost all the subjects were obese and 60% of them had OSA without evidence of daytime hypoxemia. 120 Currently, there is a paucity of data to support a causal relationship between pulmonary hypertension and obesity. However, obese individuals with previous use of anorexigenic agents had a higher incidence of pulmonary hypertension. 121 Moreover, obesity worsens the clinical course of PPH by placing the additional burden of altered respiratory mechanics on the failing right ventricle.
Chronic obstructive pulmonary disease (COPD)
Chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema, is characterized by airflow limitation that is not fully reversible. 122 Guerra, et al. studied a longitudinal cohort enrolled in the Tucson Epidemiologic Study of Airways Obstructive Diseases, including 79 patients with emphysema and 299 with chronic bronchitis. They found that patients with emphysema were more likely to be underweight, and patients with chronic bronchitis are more likely to be obese. A diagnosis of emphysema was significantly associated with a BMI less than 18.5 when compared with healthy control subjects. About 25% of patients with chronic bronchitis were overweight or obese when compared with normal weight controls. 85 Obesity in chronic bronchitis is probably because of sedentary lifestyle. 20 Paradoxically, increased BMI is associated with decreased mortality among patients with COPD. 123 However, BMI in COPD is not a good indicator of muscle mass and lower muscle mass is associated with higher mortality rates irrespective of BMI. 124 Further studies are required to better understand the pathophysiology of obesity and COPD.
Weight reduction
Weight loss results in improved lung function, oxygenation, respiratory muscle function, exercise tolerance, gas exchange, sleep quality, and daytime
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Obesity and respiratory diseases AT Murugan and G Sharma sleepiness. 30, 98, [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] Thus, successful weight loss intervention strategies have the potential to significantly reduce morbidity and mortality related to obesity-induced respiratory complications. Structured dietary and exercise programs, including pulmonary rehabilitation programs, should be considered for patients with obesity and respiratory disturbances. Oxygen saturation should be maintained >90% during exercise, particularly for patients with pulmonary hypertension, to prevent arrhythmias and exercise-induced increases in pulmonary artery pressure that may lead to syncope and circulatory collapse.
Conclusions
Obesity is a major cause of morbidity and mortality. Disturbances of respiratory function, including reduced respiratory system compliance, increased small airways resistance, impaired respiratory muscle function, increased work of breathing, impaired gas exchange, exercise intolerance, sleep-disordered breathing, and increased risks of VTE are common, particularly among severely obese patients. These changes can occur independent of any underlying parenchymal lung disease and contribute significantly to functional disability, impaired quality of life, and mortality. Weight loss can significantly decrease the risk and severity of obesity-related respiratory disturbances. Obese individuals with respiratory disturbances should be considered for inclusion in a structured rehabilitation program with dietary, behavioral, and exercise components (such as a pulmonary or cardiac rehabilitation program) in an effort to improve functional capacity and quality of life.
